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Synopsis 
The study demonstrates that virtual decision making, by senior medical staff, for stable 
glaucoma has reasonable agreement with face to face clinical decisions. There are no 
significant safety issues with virtual clinics. 
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Abstract  
Background/aims: To examine the agreement in clinical decisions of glaucoma status made 
in a virtual glaucoma clinic with those made during a face-to-face consultation. 
Methods: A trained nurse and technicians entered data prospectively for 204 patients into a 
proforma. A subsequent face-to-face clinical assessment was completed by either a glaucoma 
consultant or fellow. Proformas  were reviewed remotely by one of two additional glaucoma 
consultants and 12 months later, by the clinicians who had undertaken the original clinical 
examination. The inter-observer and intra-observer decision making agreement of virtual 
assessment versus standard care were calculated.  
Results: We identified adverse disagreement between face to face and virtual review in 7/204 
(3.4%, 95% CI: 0.9%, 5.9%) patients, where virtual review failed to predict a need to 
accelerated follow-up identified in face to face review. Mis-classification events were rare, 
occurring in 1.9% (95% CI: 0.3% and 3.8%) of assessments.  Inter-observer kappa [95% 
confidence intervals; CI] showed only fair agreement (0.24 [0.04 to 0.43]); this improved to 
moderate agreement when only consultant decisions were compared against each other (k = 
0.41  
[0.16 to 0.65]). The intra-observer agreement kappa [95% CI] for the consultant was 0.274 
[0.073 to 0.476], and for the fellow was 0.264 [0.031 to 0.497]. 
Conclusion: The low rate of adverse mis-classification, combined with the slowly 
progressive nature of most glaucoma, and the fact that patients will all be regularly re-
assessed, suggests that virtual clinics offer a safe, logistically viable option for selected 
glaucoma patients. 
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Introduction 
Chronic disease management is a particular challenge facing the United Kingdom (UK) 
National Health Service (NHS). [1] It is estimated the UK population is growing at a rate of 
0.7% per annum, and will have reached approximately 72 million by 2031. As with most 
Western countries, the UK has an increasingly ageing population; in 2003, there were 20 
million individuals over the age of 50 years and this number is predicted to increase by 36% 
by 2031. [2] Older people are disproportionately heavy users of healthcare services, with 
implications for both resource funding and management. [3] The NHS is also under 
increasing pressure to make efficiency savings. [4 5]   
 
Current models of care for many chronic diseases require that patients make repeated visits to 
hospitals and clinics in order to undergo assessments and tests. For an efficient, consultant led 
service, clinically relevant information should be presented in such a way to allow rapid 
decision making. Stable patients are then quickly identified, allowing consultants more time 
to discuss difficult management decisions with unstable patients. This requires the 
segregation of patients with the same disease process into different categories depending on 
clinical risk.   
 
Glaucoma, as an example of a chronic eye condition, is the commonest cause of irreversible 
blindness worldwide, [6] but blindness can be prevented by early diagnosis and treatment. [7] 
Chronic diseases often require lifelong monitoring with periodic treatment adjustment. It has 
been estimated that in England around half a million people suffer with glaucoma, with up to 
1.2 million suffering from ocular hypertension or suspected glaucoma; which approximates to 
2.4 million NHS outpatient visits per year. [8] There are increasing capacity problems coping 
with the number of glaucoma related out-patient appointments within the NHS hospital eye 
service (HES). Modelling predicts that this is set to worsen with current methods of NHS 
glaucoma patient management. [9] 
 
It has been suggested that a ‘virtual clinic’ model of community-based monitoring of stable 
glaucoma disease may help tackle capacity issues in the UK HES. For example,clinical test 
data can be collected by technical staff, uploaded to a server and presented to a consultant 
ophthalmologist logging on remotely.   
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Whilst there are now a number of ophthalmology services across the UK that provide 
versions of these ‘virtual clinic’ services, there is currently no evidence that this method of 
clinical management is at least equivalent to face-to-face consultations in safety and 
robustness of decision-making. The purpose of our study was to examine the agreement 
between the decisions made by clinicians reviewing patient data remotely with those made by 
clinicians undertaking a face-to-face consultation (i.e standard outpatient care). There were 
two research objectives: firstly to establish the inter-observer agreement between remote 
review clinicians and those delivering standard outpatient care, and secondly to evaluate the 
intra-observer agreement, by comparing the decisions made by clinicians who provided 
standard care with the decisions they made when reviewing patient data remotely.  
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Methods 
 
Consecutive adult glaucoma patients with a planned, greater than six monthly follow up 
frequency were considered by the Glaucoma Service to be suitable for this type of clinic.. 
Patients with poor mobility, poor visual field technique, or poor quality optic disc imaging or 
other diagnosis not suited to remote assessments were not considered suitable. Only patients 
with open angles (including pseudoexfoliation and pigment dispertion syndrome) were 
considered. The Hospital’s Performance and Information team provided the details of 
patients’ follow up schedules and over a 7 month period from March to September 2011 for 
two adult glaucoma outpatient clinics.  
 
The ‘virtual clinic’ was set up in the Hospital’s Clinical Research Facility and was staffed by 
3 technicians and an ophthalmic nurse. Patients underwent the same routine investigations 
and examinations that were to be conducted in their clinic appointment. The flow of the clinic 
is a follows: each technician manned a designated workstation: visual acuity measurement, 
visual field measurement (Humphrey Field Analyzer, Zeiss, CA), optic disc imaging. The 
latter consisted of disc and macular photography (TRC NW8, Topcon Medical Systems, 
Oakland, USA) and scanning laser ophthalmoscopy with the Heidelberg Retina Tomograph 
(HRT; Heidelberg Engineering, Heidelberg, Germany). A questionnaire was used to capture 
aspects of the patient’s symptoms and history, which was reviewed by the nurse. The nurse 
also measured and recorded intraocular pressure (IOP) data using a Goldmann Applanation 
Tonometer and made a slit-lamp assessment of the anterior segment.  The nurse then 
completed a data capture proforma that contained aspects of the clinical examination from 
that day, including any comment on the patient’s symptoms where relevant. Advice was 
offered by the nurse on common anterior segment complaints, such as blepharitis. Significant 
drop related side effects were recorded. The nurse also observed drop technique and offered 
advice where appropriate. The patient then went on to see a consultant (JC) or senior fellow 
(RP) for their face-to-face consultation. The clinicians’ observations of the patient’s 
glaucoma status and change in management were recorded. The follow up outcomes were 
subsequently risk stratified to best fit the categories required in the remote reviews and shown 
in Table 1. 
The audit department authorized the study team (audit code: CA15/GL/25) to collect data on 
the patients  for remote assessment by members as described below.  
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Patient details including ethnicity, diagnosis, general health status, angle assessment, central 
corneal thickness measurement, maximum IOP over the course of their follow up in the 
service, results of any phasing examinations and drop usage were recorded on a separate 
paper proforma, along with a summary of the clinical assessment at their preceding outpatient 
appointment. These data, along with all current and previous visual field plots and current 
HRT results (including trend analysis where available) were available for ‘remote review’. 
Consultants undertaking the remote review (PF, KB) also had access to digital optic disc 
photographs.  
Remote reviewers were asked to indicate when the next follow up visit should be, based on 
the patient’s risk of developing significant visual loss over the follow up interval (Table 1). 
They were also advised that they could comment upon the glaucoma status and whether they 
noted any other factor in the examination that warranted further investigation.  
 
Very low risk Low risk Medium risk High risk Emergency 
Stable review 
appointment 
12 months 
Stable review 
appointment 6 
months 
Consultant 
clinic 
appointment 
within 4 
months 
Consultant 
clinic 
appointment 
within 2 weeks 
Immediate 
referral to 
glaucoma 
clinic or A&E 
Table 1: risk stratification for remote assessors 
 
Twelve months after the patients’ visits, the two clinicians who conducted the face-to-face 
assessment (JC and RP) were asked to perform the remote review process in order to 
determine whether their management decisions would be the same as that made when they 
undertook the face-to-face assessment. The time frame was an attempt to prevent the 
clinicians from recalling their original decisions. 
Following collection of data, the characteristics of the clinical findings that led to the clinical 
conclusion of progressive change were presented to the co-authors. Agreement between the 
authors that there was evidence of disease progression was then achieved before data analysis 
was completed. 
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Data analysis 
Cohen’s Kappa statistic used to assess both interobserver (i.e. face to face clinicians’ versus 
remote review clinicians’) agreement and intraobserver (same clinicians’ face to face versus 
their deferred/later remote review) agreement.   
Using the face-to-face review as the reference standard, the sensitivity and specificity of the 
ability of the virtual clinic assessment to detect unstable disease was also calculated.  We also 
looked at agreement between specific clinicians.  
 
Results 
Two hundred and eighty-six patients reviewed over a 6 month period and screened for 
eligibility for inclusion, with 217 meeting the criteria for having their data remotely 
reviewed. Data for 13 patients were irrevocably damaged following a flooding incident; thus 
complete data were available for 204 patients. 
 
The primary diagnoses were: primary open angle glaucoma n=88 (43%), primary ocular 
hypertension n= 59 (29%), glaucoma suspects n= 33 (16%), secondary glaucoma n = 18 
(9%), secondary OHT n = 4 (2%) and primary angle closure n = 2 (1%). The average 
[standard deviation; range] visual field mean deviation in the better and worse eyes were -
1.63 [2.66; -15.14 to 3.35] dB and -4.96 [5.84; -27.94 to 1.99] dB respectively.  
 
At the face-to-face assessment, 21 (10%) patients were identified as being ‘unstable’, in that 
they required a change in management. In the virtual clinic assessment, patients deemed as 
‘very low’ or ‘low risk’ were classed as ‘stable’, whilst those deemed ‘medium – high risk’ or 
‘emergency’ were recorded as ‘unstable’. Where the reviewer had indicated that the 
classification was the result of a non-glaucomatous issue, and that the glaucoma itself was 
stable, patients were marked as ‘stable’. 
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Inter-observer agreement 
All 5 authors reviewed the hospital medical records for patients considered unstable on face 
to face assessment, and stable on virtual assessment (N= 14). Thus, consensus agreement was 
ensured for the face-to-face clinical suspicion of “unstable” glaucoma or OHT. This 
consensus opinion led to 7 patients deemed ‘unstable’ at their face-to-face review as being 
reclassified ‘stable’. The kappa table is shown in Table 2. The kappa statistic for the inter-
observer agreement, comparing face-to-face with virtual assessment, was 0.320 [95% 
confidence intervals, CI, 0.112 to 0.529], indicating ‘fair agreement’. The sensitivity and 
specificity [95% CI] of the virtual clinic was 50.0 [23.0 to 77.0]% and 91.6[86.7 to 95.1]%, 
respectively.  
 
 Face-to-face 
‘stable’ 
Face-to-face 
‘unstable’ 
Total 
Remote 
‘stable’ 
174 7 181 
Remote 
‘unstable’ 
16 7 23 
Total 190 14 204 
 
Table 2: Kappa table for interobserver agreement analysis.  
Face to face reviews were performed by either a consultant or senior glaucoma fellow 
(JC,RP) and remote reviews were performed by one of 2 consultants (PF, KB). Agreement 
was ‘fair’ between face to face and remote review. 
 
Furthermore, we examined the agreement between consultants only, excluding any data from 
senior trainees (fellows). Table 3 illustrates the agreement between consultant face-to-face 
review and remote assessment. This suggests that consultant virtual clinic decisions agree 
well with consultant face-to-face management decisions.  
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Grade Remote decision 
agreement kappa  
[95% CI] 
% Sensitivity 
[95% CI] 
% Specificity 
[95% CI] 
Consultant 0.406  
[0.161 to 0.651] 
75.0 
[34.9 to 96.8] 
89.1 
[81.7 to 94.2] 
 
Table 3: Agreement, sensitivity and specificity between virtual clinic decisions and 
clinical management decisions made by consultant. The data suggest that consultants 
undertaking remote reviews agree well with the consultant undertaking face-to-face review. 
 
The 7/204 (3.4%, 95% CI: 0.9%, 5.9%) patients who were “misclassified” as stable during 
the virtual clinic assessment, but ‘unstable’ at the face-to-face review, comprised of one 
patient with POAG, 2 glaucoma suspects and 4 patients with glaucoma secondary to either 
pseudoexfoliation or pigment dispersion syndrome. Further details of their diagnoses and 
visual status are reported in Table 4. The characteristics suggest that 5 of the patients had 
‘early’ disease based on the depth of their visual field defect. [10] The other 2 with more 
advanced disease were recommended to re-attend in 6 months in the virtual clinic assessment.   
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Diagnosis Age 
(years) 
RVA 
(Snellen) 
LVA 
(Snellen) 
RMD 
(dB) 
LMD 
(dB) 
Recommended 
follow up 
remote review 
PXF 
glaucoma 
84 6/24 6/12 -1.59 -0.84 12 months 
PXF 
glaucoma 
74 6/6 6/6 -0.74 -2.79 12 months 
PXF 
glaucoma 
61 6/6 6/6 -3.16 -3.74 6 months 
PDG 66 6/6 6/9 -4.11 -15.81 6 months 
POAG 80 6/12 6/6 -22.16 -12.76 6 months 
Suspect 53 6/5 6/6 0.22 0.38 12 months 
Suspect 65 6/5 6/5 -1.08 -3.44 6 months 
Table 4: Characteristics of patients who were not identified as progressing at the remote 
review.Key: PXF = pseudoexfoliation, PDG = pigment dispersion glaucoma, POAG = 
primary open angle glaucoma, VA = visual acuity, MD = visual field mean deviation.  
 
Intraobserver agreement 
The consultant and fellow undertaking clinical examinations performed ‘virtual clinic’ 
assessments for 194 of the original 204 patients.  The intraobserver agreement kappa [95% 
CI] for the consultant was 0.274 [0.073 to 0.476], and for the fellow was 0.264 [0.031 to 
0.497]. The sensitivity [95% CI] and specificity [95% CI] of ‘virtual clinic’ management 
decisions were 75.0 [34.9 to 96.8] % and 81.0 [72.1 to 88.0] % for the consultant and 60.0 
[26.2 to 87.8] % and 78.9 [67.6 to 87.7] % for the fellow, respectively. 
  
12 
 
In total, 6 patients were deemed as ‘stable’ during the virtual clinic assessment (4 by the 
Fellow and 2 by the Consultant), and were deemed unstable during the face-to-face 
examination.  During the remote review, the disc imaging of the two patients progressing in 
the Consultants’ clinical assessments was not available.  
 
As expected, co-pathology was identified in the clinical assessment. Potentially significant 
symptoms were successfully identified during the remote assessment, but were rare (diplopia 
1%, amaurosis fugax 0.5%, photopsia 0.5%). Appropriate, additional investigations were 
recommended for all of these patients.  One (0.5%) leaking trabeculectomy bleb was 
identified clinically but not via the remote assessment. Common, non-sight threatening 
anterior segment disorders (episcleritis, blepharitis, drop allergy) that required additional 
treatment as a result of the clinical assessment, were identified remotely in only 1 of 6 
(16.6%) of patients, through the patient questionnaire. New retinal findings (dry ARMD, 
epiretinal membrane) were identified in 4 (2%) of patients on clinical assessment and half of 
these were identified with the remote assessment from fundus photography. 
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Discussion 
Our study aimed to evaluate agreement between ophthalmologists’ management decisions 
made during the standard outpatient visit and a ‘virtual clinic’. Intra-observed agreement for 
both Consultant and Fellow grades were similar (0.27 versus 0.26) and only moderate and the 
classification categories may be too arbitrary, particularly with the separation of six and 
twelve months into low and very low risk. The results suggest that the virtual clinic has low 
sensitivity at detecting unstable disease. However, closer inspection shows that agreement 
and sensitivity are dependent on the grade of the clinician, with non-consultants adopting a 
more cautious and less consistent approach in their management decisions. Decision making 
between remote and face-to-face assessments are likely to differ, but the identification of 
progressing disease is critical. The wide range in confidence intervals for sensitivity suggest 
that far larger and long-term studies are required to confirm virtual clinic sensitivity for 
detecting progressing disease. The number of progressing patients is expected to be small in 
this population of patients. 
 
A similar study was conducted by Gupta et al in a tertiary ophthalmic referral centre in India. 
[11] Agreement was assessed between ophthalmologists diagnosing and managing patients 
during their clinical examination with those made via teleophthalmology review.  The kappa 
statistic for the diagnosis and management of glaucoma cases was 0.52 and 0.53, 
respectively. Another study examining the agreement between a district hospital 
ophthalmologist and a specialist glaucomatologist undertaking teleophthalmology reviews 
found similar levels of agreement in diagnosing glaucoma in African eyes.[12] The relatively 
low level of agreement in management decisions not unusual. A single ophthalmologist 
showed some disagreement with their own management decisions when presented with cases 
a period after their initial clinical examination. [13] There exists a diversity of clinical 
opinion amongst glaucomatologists on the best management options for individual patients. 
[14]  
 
Decisions based on multiple investigations, all open to interpretation, are likely to lead to 
variations in recommended outcomes. In our study, the more experienced the clinicians were 
prepared to accept more uncertainty and recommend longer follow up periods. The study 
design forced clinicians to classify the patient’s risk of glaucoma progression. The arbitrary 
distinction between stable (≥6 months follow up) and unstable (<6 months follow up) may 
have led to over representation of poor stability identified in the study (table 2). 
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All of the patients remained under the hospitals care. This continuation of care would give an 
opportunity for ‘instability’ to be detected at subsequent visits. Glaucoma progression can be 
difficult to detect particularly if based on clinician judgement of paper-based visual field 
printouts. [15] With the inherent noise within visual field test results, clinicians may 
reasonably adopt a ‘wait and see’ approach to managing suspected disease progression. [16] 
In this study, the two patients (2/204, 1.9%, 95% CI: 0.3, 3.8) in whom there was relatively 
advanced visual field loss and disagreement between clinical assessment and virtual 
assessment were recommended to be seen again in 6 months. Progression seen at that virtual 
assessment would instigate a change in management. Large scale modelling studies have 
shown that patients with early disease, defined as less than -6dB of mean deviation sensitivity 
loss,[10] are at low risk of progressing to blindness once they are in the ophthalmology 
healthcare system. [17] Thus, perhaps the traditional outpatient consultation should remain 
for patients with worse disease status, who are at a higher risk of developing significant 
visual loss over their lifetime. 
Whilst concerning symptoms, suggestive of new onset and non-glaucoma associated eye 
disease, were identified remotely; other slowly changing processes, such as age related 
macular degeneration were not well recognised and patients should be advised of the 
limitations and recommended to undertake regular community optometry assessments. 
Suitable correspondence between HES and community optometrists is important to clarify 
the limitations of virtual review clinics. Local side effects to treatment and common ocular 
surface diseases, such as blepharitis, are poorly identified on remote assessments and a 
suitably trained ophthalmic nurse present at the data gathering assessments will identify and 
manage most of these issues. The nurse can also make recommendations on the extent of 
visually significant lens opacity. 
 
In summary, our study suggests that the use of a virtual clinic in the management of stable 
glaucoma patients has some limitations, and may not provide the level of sensitivity at 
detecting unstable disease that is found in the standard outpatient environment. However, our 
study identified no serious safety concerns, and suggests that significant mis-classification 
events are rare, occurring between in 0.3% and 3.8% of assessments. The slowly progressive 
nature of most glaucoma and the periodic re-assessments, suggest that virtual clinics offer a 
safe, logistically viable option for selected patients. We recommend patients enrolled in such 
schemes be those at low risk of progression to significant visual loss over each follow up 
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interval. Remote assessments are most reliably performed by consultant level glaucoma 
specialist. Patients should be encouraged to see their optometrist routinely to assess for new, 
unrelated eye disease. 
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